BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 38731908)

  • 21. Atrial reverse remodeling represented by the atrial conduction time in persistent atrial fibrillation patients after catheter ablation: its impact on predicting late atrial fibrillation recurrence.
    Hori Y; Nakahara S; Fukuda R; Sato H; Ukaji T; Koshikawa Y; Nishiyama N; Ishikawa T; Kobayashi S; Taguchi I
    J Cardiol; 2020 May; 75(5):521-528. PubMed ID: 31666177
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrence After Atrial Fibrillation Ablation and Investigational Biomarkers of Cardiac Remodeling.
    El-Harasis MA; Quintana JA; Martinez-Parachini JR; Jackson GG; Varghese BT; Yoneda ZT; Murphy BS; Crawford DM; Tomasek K; Su YR; Wells QS; Roden DM; Michaud GF; Saavedra P; Estrada JC; Richardson TD; Kanagasundram AN; Shen ST; Montgomery JA; Ellis CR; Crossley GH; Eberl M; Gillet L; Ziegler A; Shoemaker MB
    J Am Heart Assoc; 2024 Mar; 13(6):e031029. PubMed ID: 38471835
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Left atrial appendage flow velocity and time from P-wave onset to tissue Doppler-derived A' predict atrial fibrillation recurrence after radiofrequency catheter ablation.
    Fukushima K; Fukushima N; Ejima K; Kato K; Sato Y; Uematsu S; Arai K; Manaka T; Takagi A; Ashihara K; Shoda M; Hagiwara N
    Echocardiography; 2015 Jul; 32(7):1101-8. PubMed ID: 25362992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Atrial fibrillation: recent advances in understanding the role of microRNAs in atrial remodeling with an electrophysiological overview.
    Poudel P; Xu Y; Cui Z; Sharma D; Tian B; Paudel S
    Cardiology; 2015; 131(1):58-67. PubMed ID: 25871909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of obesity on catheter ablation of atrial fibrillation: Patient characteristics, procedural complications, outcomes, and quality of life.
    Tabaja C; Younis A; Santageli P; Farwati M; Braghieri L; Nakagawa H; Saliba WI; Madden R; Bouscher P; Kanj M; Callahan TD; Martin D; Bhargava M; Chung M; Baranowski B; Nakhla S; Sroubek J; Lee J; Taigen T; Wazni OM; Hussein AA
    J Cardiovasc Electrophysiol; 2023 Aug; 34(8):1648-1657. PubMed ID: 37493505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromosome 4q25 variants and biomarkers of myocardial fibrosis in patients with atrial fibrillation.
    Choi JI; Baek YS; Roh SY; Piccini JP; Kim YH
    J Cardiovasc Electrophysiol; 2019 Oct; 30(10):1904-1913. PubMed ID: 31393025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Sinus Node Recovery Time after Long-Standing Atrial Fibrillation Termination on the Long-Term Outcome of Catheter Ablation.
    Yamaguchi N; Okumura Y; Watanabe I; Nagashima K; Takahashi K; Iso K; Watanabe R; Arai M; Mano H; Kogawa R; Kurokawa S; Ohkubo K; Nakai T; Hirayama A; Sonoda K; Tosaka T
    Int Heart J; 2018 May; 59(3):497-502. PubMed ID: 29743409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of Midregional N-Terminal Pro-Atrial Natriuretic Peptide and Soluble Suppression of Tumorigenicity 2 Levels on Heart Rhythm in Patients Treated With Catheter Ablation for Atrial Fibrillation: The Biorhythm Study.
    Badoz M; Serzian G; Favoulet B; Sellal JM; De Chillou C; Hammache N; Laurent G; Mebazaa A; Ecarnot F; Bardonnet K; Seronde MF; Schiele F; Meneveau N
    J Am Heart Assoc; 2021 Jul; 10(13):e020917. PubMed ID: 34187182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ion Channel and Structural Remodeling in Obesity-Mediated Atrial Fibrillation.
    McCauley MD; Hong L; Sridhar A; Menon A; Perike S; Zhang M; da Silva IB; Yan J; Bonini MG; Ai X; Rehman J; Darbar D
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008296. PubMed ID: 32654503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An atrial fibrosis-based approach for atrial fibrillation ablation.
    Han FT; Marrouche N
    Future Cardiol; 2015; 11(6):673-81. PubMed ID: 26609731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of inflammation-mediated myocardial fibrosis on the risk of recurrence after successful ablation of atrial fibrillation - the FIBRO-RISK study: Protocol for a non-randomized clinical trial.
    Korodi S; Toganel R; Benedek T; Hodas R; Chitu M; Ratiu M; Kovacs I; Mester A; Benedek I
    Medicine (Baltimore); 2019 Mar; 98(9):e14504. PubMed ID: 30817568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of recurrent atrial fibrillation following catheter ablation.
    Mohanty S; Della Rocca DG; Gianni C; Trivedi C; Mayedo AQ; MacDonald B; Natale A
    Expert Rev Cardiovasc Ther; 2021 Mar; 19(3):237-246. PubMed ID: 33678103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of Pulmonary Vein Anatomy on the Outcomes of Catheter Ablation for Atrial Fibrillation.
    Istratoaie S; Roșu R; Cismaru G; Vesa ȘC; Puiu M; Zdrenghea D; Pop D; Buzoianu AD
    Medicina (Kaunas); 2019 Nov; 55(11):. PubMed ID: 31690031
    [No Abstract]   [Full Text] [Related]  

  • 34. Long P-wave duration immediately after pulmonary vein isolation on radiofrequency catheter ablation for atrial fibrillation predicts clinical recurrence: correlation with atrial remodeling in persistent atrial fibrillation.
    Ohguchi S; Inden Y; Yanagisawa S; Shigematsu T; Yasuda K; Katagiri K; Oguri M; Murohara T
    Heart Vessels; 2022 Mar; 37(3):476-488. PubMed ID: 34432100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pre-ablation levels of brain natriuretic peptide are independently associated with the recurrence of atrial fibrillation after radiofrequency catheter ablation in patients with nonvalvular atrial fibrillation.
    Miake J; Kato M; Ogura K; Iitsuka K; Okamura A; Tomomori T; Tsujimoto D; Kato M; Yamamoto K
    Heart Vessels; 2019 Mar; 34(3):517-526. PubMed ID: 30238353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Circulating MicroRNA-21 Correlates With Left Atrial Low-Voltage Areas and Is Associated With Procedure Outcome in Patients Undergoing Atrial Fibrillation Ablation.
    Zhou Q; Maleck C; von Ungern-Sternberg SNI; Neupane B; Heinzmann D; Marquardt J; Duckheim M; Scheckenbach C; Stimpfle F; Gawaz M; Schreieck J; Seizer P; Gramlich M
    Circ Arrhythm Electrophysiol; 2018 Jun; 11(6):e006242. PubMed ID: 29848477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atrial Remodeling Following Catheter Ablation for Atrial Fibrillation-Mediated Cardiomyopathy: Long-Term Follow-Up of CAMERA-MRI Study.
    Sugumar H; Prabhu S; Voskoboinik A; Young S; Gutman SJ; Wong GR; Parameswaran R; Nalliah CJ; Lee G; McLellan AJ; Taylor AJ; Ling LH; Kalman JM; Kistler PM
    JACC Clin Electrophysiol; 2019 Jun; 5(6):681-688. PubMed ID: 31221354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparisons of the underlying mechanisms of left atrial remodeling after repeat circumferential pulmonary vein isolation with or without additional left atrial linear ablation in patients with recurrent atrial fibrillation.
    Yang CH; Chou CC; Hung KC; Wen MS; Chang PC; Wo HT; Lee CH; Lin FC
    Int J Cardiol; 2017 Feb; 228():449-455. PubMed ID: 27870975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of cryoballoon-based catheter ablation on left atrial structural and potential electrical remodeling in patients with paroxysmal atrial fibrillation.
    Canpolat U; Aytemir K; Özer N; Oto A
    J Interv Card Electrophysiol; 2015 Nov; 44(2):131-9. PubMed ID: 26238480
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reverse left ventricular structural remodeling after catheter ablation of atrial fibrillation in patients with preserved left ventricular function: Insights from cardiovascular magnetic resonance native T1 mapping.
    Kowallick JT; Staab W; Schuster A; Backhaus SJ; Weber-Krüger M; Bauer L; Sohns C; Lotz J; Hasenfuß G; Lüthje L; Zabel M; Bergau L
    Heart Rhythm; 2019 Mar; 16(3):424-432. PubMed ID: 30248459
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.